Literature DB >> 9693691

Tracking substance abusers in longitudinal research: understanding follow-up contact difficulty.

M A Walton1, C S Ramanathan, T M Reischl.   

Abstract

Studies examining follow-up contact difficulty provide useful information for planning longitudinal studies and for assessing the validity of follow-up data. Contact difficulty was examined among 96 substance abusers following substance abuse treatment. Interview completion rates at the 3-month and 6-month follow-ups were 93 and 97%, respectively. The extent of contact efforts required to complete follow-up interviews varied substantially but tended to be greater at the 3-month follow-up than at the 6-month follow-up. Contact difficulty was related to reuse of substances at the 3-month and at the 6-month follow-ups with reusers requiring greater contact efforts than abstainers. None of the baseline individual and contextual variables examined significantly predicted level of contact effort at follow-ups. Attrition-related validity implications are discussed along with practical suggestions for planning tracking efforts.

Mesh:

Year:  1998        PMID: 9693691     DOI: 10.1023/a:1022128519196

Source DB:  PubMed          Journal:  Am J Community Psychol        ISSN: 0091-0562


  12 in total

1.  A replicable model for achieving over 90% follow-up rates in longitudinal studies of substance abusers.

Authors:  Christy K Scott
Journal:  Drug Alcohol Depend       Date:  2004-04-09       Impact factor: 4.492

2.  The provision of cell phones as a recruitment and retention strategy for people who inject drugs enrolling in a randomized trial.

Authors:  Catherine Stewart; Hannah Kopinski; Jane Liebschutz; Inga Holmdahl; Julia Keosaian; Debra Herman; Bradley Anderson; Michael Stein
Journal:  Drug Alcohol Depend       Date:  2018-01-11       Impact factor: 4.492

3.  The effectiveness of community-based delivery of an evidence-based treatment for adolescent substance use.

Authors:  Sarah B Hunter; Rajeev Ramchand; Beth Ann Griffin; Marika J Suttorp; Daniel McCaffrey; Andrew Morral
Journal:  J Subst Abuse Treat       Date:  2011-12-29

4.  Regulatory Issues Encountered when Conducting Longitudinal Substance Abuse Research.

Authors:  Elizabeth Evans; Debra A Murphy; Christine E Grella; Michele Mouttapa; Yih-Ing Hser
Journal:  J Drug Issues       Date:  2008-10-01

5.  Correlates related to follow-up in a community engagement program in North Central Florida.

Authors:  Ayodeji Otufowora; Yiyang Liu; Deepthi S Varma; Catherine W Striley; Linda B Cottler
Journal:  J Community Psychol       Date:  2020-09-19

6.  Modifiable risk factors of ecstasy use: risk perception, current dependence, perceived control, and depression.

Authors:  Kit Sang Leung; Arbi Ben Abdallah; Jan Copeland; Linda B Cottler
Journal:  Addict Behav       Date:  2009-10-18       Impact factor: 3.913

7.  Tracking inner city substance users from the emergency department: how many contacts does it take?

Authors:  Rebecca Cunningham; Maureen A Walton; Shanti P Tripathi; Ryan Outman; Regan Murray; Brenda M Booth
Journal:  Acad Emerg Med       Date:  2008-02       Impact factor: 3.451

8.  Patterns and predictors of attrition in a trial of a housing intervention for homeless people with mental illness.

Authors:  Scott Veldhuizen; Carol E Adair; Christian Methot; Brianna C Kopp; Patricia O'Campo; Jimmy Bourque; David L Streiner; Paula N Goering
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-06-12       Impact factor: 4.328

9.  Assessing the Sensitivity of Treatment Effect Estimates to Differential Follow-Up Rates: Implications for Translational Research.

Authors:  Beth Ann Griffin; Daniel McCaffrey; Rajeev Ramchand; Sarah B Hunter; Marika Suttorp
Journal:  Health Serv Outcomes Res Methodol       Date:  2012-06-01

10.  Ability to Reach Low-Income Smokers Enrolled in a Randomised Controlled Trial Varies with Time of Month.

Authors:  Kathryn Hawk; Ruizhi Shi; June Weiss; Robert Makuch; Benjamin Toll; Steven L Bernstein
Journal:  J Smok Cessat       Date:  2017-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.